ライフサイエンスコーパス: luteinizing hormone-releasing hormone

1 g orexin, melanin-concentrating hormone, and luteinizing hormone-releasing hormone.

2 steroid ablation using leuprolide acetate, a luteinizing hormone-releasing hormone agonist (LHRHa), i

3 d) (PLGA) microspheres encapsulating a model luteinizing hormone-releasing hormone agonist (LHRHa)-ba

4 Luteinizing hormone-releasing hormone agonist (LHRHa; le

5 AST, which was defined as 6 months of both a luteinizing hormone-releasing hormone agonist and an ant

6 ts receiving combined androgen blockade with luteinizing hormone-releasing hormone agonist and bicalu

7 t/aromatase inhibitor per local guidelines (+luteinizing hormone-releasing hormone agonist in pre-/pe

8 Abiraterone plus luteinizing hormone-releasing hormone agonist is active

9 les, followed by total androgen suppression (luteinizing hormone-releasing hormone agonist plus bical

10 raterone 1 g daily plus prednisone 10 mg and luteinizing hormone-releasing hormone agonist until prog

11 tients were randomized soon after initiating luteinizing hormone-releasing hormone agonist with antia

12 n deprivation (AD) to cixutumumab added to a luteinizing hormone-releasing hormone agonist with bical

13 S; two injections of every-3-months depot of luteinizing hormone-releasing hormone agonist) to primar

14 Patients were randomly assigned 2:1 to a luteinizing hormone-releasing hormone agonist, bicalutam

15 (arm 1) or RT plus TAS (arm 2) consisting of luteinizing hormone-releasing hormone agonist/antagonist

16 STAD was 6 months of luteinizing hormone-releasing hormone agonist/antagonist

17 Bilateral orchiectomy or luteinizing hormone releasing hormone agonists are the r

18 Injectable luteinizing hormone-releasing hormone agonists (e.g., le

19 Luteinizing hormone-releasing hormone agonists (leuproli

20 Bilateral orchiectomy or luteinizing hormone-releasing hormone agonists are recom

21 ; and three, when chemical suppression using luteinizing hormone-releasing hormone agonists is the ch

22 For luteinizing hormone-releasing hormone, all but two expec

23 ombesin (AN-215), somatostatin (AN-238), and luteinizing hormone-releasing hormone (AN-207) consisted

24 Luteinizing hormone releasing hormone analog (LHRHa, des

25 state cancer were performed before and after luteinizing hormone-releasing hormone analog treatment.

26 of 5 ng per milliliter or higher received a luteinizing hormone-releasing hormone analogue and an an

27 Whether the administration of luteinizing hormone-releasing hormone analogues (LHRHa)

28 All patients underwent administration of the luteinizing hormone-releasing hormone antagonist degarel

29 d cutaneous depolarization were blocked by a luteinizing hormone-releasing hormone antagonist.

30 the delivery of targeted therapeutic agents [Luteinizing Hormone-Releasing Hormone conjugated paclita

31 Hormone conjugated paclitaxel (PTX-LHRH) and Luteinizing Hormone-Releasing Hormone conjugated prodigi

32 in, corticotropin-releasing factor, galanin, luteinizing hormone-releasing hormone, enkephalin, subst

33 Luteinizing hormone-releasing hormone immunoreactivity w

34 rporation into targeted cytotoxic analogs of luteinizing hormone-releasing hormone intended for cance

35 odoxorubicin (AN-201) conjugated to [D-Lys6] luteinizing hormone-releasing hormone (LH-RH) (AN-207),

36 ound that the t(1/2) of AN-152, an analog of luteinizing hormone-releasing hormone (LH-RH) containing

37 Treatment with antagonists of luteinizing hormone-releasing hormone (LH-RH) leads to d

38 bit nitric oxidergic (NOergic) activation of luteinizing hormone-releasing hormone (LH-RH) release fr

39 eloped a targeted cytotoxic analog AN-207 of luteinizing hormone-releasing hormone (LH-RH), consistin

40 152, a conjugate of doxorubicin and [D-Lys6]-luteinizing hormone-releasing hormone (LH-RH), is more p

41 Antagonists of luteinizing hormone-releasing hormone (LH-RH), unlike th

42 d into agonistic and antagonistic analogs of luteinizing hormone-releasing hormone (LH-RH).

43 synthesis, is involved in the suppression of luteinizing hormone releasing hormone (LHRH) before pube

44 favorable for the release of a neuropeptide, luteinizing hormone releasing hormone (LHRH) from these

45 Luteinizing hormone releasing hormone (LHRH) gene transc

46 n of prostaglandin E2, which then stimulates luteinizing hormone releasing hormone (LHRH) neurons to

47 dy single-chain variable fragment (scFv) and luteinizing hormone releasing hormone (LHRH) peptide, re

48 Exogenous luteinizing hormone releasing hormone (LHRH) potentiated

49 Cytotoxic analogue of luteinizing hormone releasing hormone (LHRH), AN-207, bi

50 Irradiation of luteinizing hormone releasing hormone (LHRH), growth hor

51 n releasing hormone-1 [GnRH-1, also known as luteinizing hormone releasing hormone (LHRH)] neurons ca

52 Previously, we have shown that two types of luteinizing hormone-releasing hormone (LHRH) -like neuro

53 The effects of depot formulations of the luteinizing hormone-releasing hormone (LHRH) agonist Dec

54 Treatment with a luteinizing hormone-releasing hormone (LHRH) agonist inc

55 orticotropic hormone (ACTH) and hypothalamic luteinizing hormone-releasing hormone (LHRH) agonist, [D

56 Ovarian suppression with luteinizing hormone-releasing hormone (LHRH) agonists is

57 the recent developments on BPH therapy with luteinizing hormone-releasing hormone (LHRH) antagonist

58 tance and (5) a modified synthetic analog of luteinizing hormone-releasing hormone (LHRH) as a target

59 gs (prodigiosin or paclitaxel) conjugated to Luteinizing Hormone-Releasing Hormone (LHRH) for the spe

60 These drugs were functionalized with Luteinizing Hormone-Releasing hormone (LHRH) ligands who

61 Neurons differentiating into the luteinizing hormone-releasing hormone (LHRH) neuroendocr

62 ergic expression coincides with migration of luteinizing hormone-releasing hormone (LHRH) neurons fro

63 id (GABAergic) synaptic input onto embryonic luteinizing hormone-releasing hormone (LHRH) neurons mai

64 Luteinizing hormone-releasing hormone (LHRH) neurons mig

65 Luteinizing hormone-releasing hormone (LHRH) neurons mig

66 Luteinizing hormone-releasing hormone (LHRH) neurons ori

67 Luteinizing hormone-releasing hormone (LHRH) neurosecret

68 uropeptide Y (NPY) potentiates the effect of luteinizing hormone-releasing hormone (LHRH) on luteiniz

69 Functionalized with luteinizing hormone-releasing hormone (LHRH) peptide via

70 To investigate the possibility that a second luteinizing hormone-releasing hormone (LHRH) population

71 Importantly, SSA induced by luteinizing hormone-releasing hormone (LHRH) receptor an

72 To understand the mechanism of pulsatile luteinizing hormone-releasing hormone (LHRH) release, we

73 low doses (5-30 nM) induced large amounts of luteinizing hormone-releasing hormone (LHRH) release, wh

74 implicated in the neuroendocrine control of luteinizing hormone-releasing hormone (LHRH) secretion a

75 estigate the mechanism by which Mn2+ induces luteinizing hormone-releasing hormone (LHRH) secretion f

76 s by which the neuroendocrine brain controls luteinizing hormone-releasing hormone (LHRH) secretion.

77 Luteinizing hormone-releasing hormone (LHRH) was used as

78 large doses of Cetrorelix, an antagonist of luteinizing hormone-releasing hormone (LHRH), reduces le

79 naling pathway that prompts the secretion of luteinizing hormone-releasing hormone (LHRH), the neurop

80 osecretory neurons to stimulate secretion of luteinizing hormone-releasing hormone (LHRH), the neurop

81 ure activation of those neurons that produce luteinizing hormone-releasing hormone (LHRH), the neurop

82 t of norepinephrine (NE) on the secretion of luteinizing hormone-releasing hormone (LHRH), the neurop

83 ne (LH) surge that is prompted by a surge in luteinizing hormone-releasing hormone (LHRH).

84 othalamic neurons secreting the neuropeptide luteinizing hormone-releasing hormone (LHRH).

85 ng afferent pathways to neurons synthesizing luteinizing hormone-releasing hormone (LHRH, also known

86 (68)Ga-PSMA-11 PET imaging in hormone-naive (luteinizing hormone-releasing hormone [LHRH] +/- bicalut

87 itive tumors also received letrozole (plus a luteinizing hormone-releasing hormone [LHRH] agonist if

88 diation plus immediate androgen suppression (luteinizing hormone-releasing hormone [LHRH] agonist), w

89 that FSHRF might be an analogue of mammalian luteinizing hormone-releasing hormone (m-LHRH) and evalu

90 coexpressed in neurons containing mammalian luteinizing hormone-releasing hormone (m-LHRH).

91 k suggests that cytotoxic peptide analogs of luteinizing hormone-releasing hormone, somatostatin, and

92 s monotherapy or with adjuvant castration or luteinizing hormone-releasing hormone superagonists to b